We developed a correlative model at high resolution for predicting the distribution of one of the main vectors of Crimean-Congo haemorrhagic fever virus (CCHFV), Hyalomma marginatum, in a recently colonised area, namely southern France. About 931 H. marginatum adult ticks were sampled on horses from 2016 to 2019 and 2021 in 14 southern French departments, which resulted in the first H. marginatum detection map on a large portion of the national territory. Such updated presence/absence data, as well as the mean number of H. marginatum per examined animal (mean parasitic load) as a proxy of tick abundance, were correlated to multiple parameters describing the climate and habitats characterising each collection site, as well as movements of horses as possible factors influencing tick exposure. In southern France, H. marginatum was likely detected in areas characterised by year-long warm temperatures and low precipitation, especially in summer and mostly concentrated in autumn, as well as moderate annual humidity, compared to other sampled areas. It confirms that even in newly invaded areas this tick remains exclusively Mediterranean and cannot expand outside this climatic range. Regarding the environment, a predominance of open natural habitats, such as sclerophyllous vegetated and sparsely vegetated areas, were also identified as a favourable factor, in opposition to urban or peri-urban and humid habitats, such as continuous urban areas and inland marshes, respectively, which were revealed to be unsuitable. Based on this model, we predicted the areas currently suitable for the establishment of the tick H. marginatum in the South of France, with relatively good accuracy using internal (AUC = 0.66) and external validation methods (AUC = 0.76This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Introduction Underestimation of zoonoses is exacerbated in low and middle-income countries due mainly to inequalities with serious consequences in healthcare. This is difficult to gauge and reduce the impact of those diseases. Our study focuses on Paraguay, where the livestock industry is one of the major components of the country’s economy. Therefore, the rationale of this study was to develop a case study in Paraguay to estimate the dual impact of zoonotic diseases on both the human health and animal health sector and thus determine the societal burden of such diseases. Methodology/Principal findings We conducted a systemic review (including a meta-analysis) to assess the burden of zoonoses in Paraguay, including official reports and grey literature of disease incidence and prevalence. We estimated the Disability Adjusted Life Years (DALYs) and Zoonosis Disability Adjusted Life Years (zDALYs) to measure the difference between the current health status and the desired health situation of animals and the Paraguayan population based on 50 zoonotic diseases suggested by the WHO (World Health Organization), OIE (World Organization for Animal Health) and the National Health in Paraguay. The total DALYs represent 19,384 (95% CI: from 15,805 to 29,733), and zDALYs, 62,178 (95% CI: from 48,696 to 77,188). According to the results, the priority pathogens for DALYs are E. coli, Trypanosoma cruzi, Leishmania spp, and Toxoplasma gondii. When we include the additional animal health burden, the most important pathogens are Brucella spp, E. coli, Trypanosoma cruzi, and Fasciola hepatica for zDALYs. Conclusion/Significance This is the first study to integrate DALYs and zDALYs with important clues related to the health status of Paraguay. Through DALYs and zDALYs, our perspective becomes more complete because we consider not only human health but also animal health. This is important for setting priorities in disease control, especially in a society where livestock contribute significantly to the economy and to human well-being.

Background Zoonoses can cause a substantial burden on both human and animal health. Globally, estimates of the dual (human and animal) burden of zoonoses are scarce. Therefore, this study aims to quantify the dual burden of zoonoses using a comparable metric, “zoonosis Disability Adjusted Life Years” (zDALY). Methodology We systematically reviewed studies that quantify in the same article zoonoses in animals, through monetary losses, and in humans in terms of Disability Adjusted Life Years (DALYs). We searched EMBASE, Web of Science, Scopus, PubMed, and Google Scholar. We excluded articles that did not provide the data to estimate the zDALY or those for which full text was not available. This study was registered at PROSPERO, CRD42022313081. Principal findings/Significance We identified 512 potentially eligible records. After deduplication and screening of the title and abstract, 23 records were assessed for full-text review. Fourteen studies were included in this systematic review. The data contains estimates from 10 countries, a study at continental level (Asia and Africa), and 2 studies on a global scale. Rabies was the most frequently reported zoonosis where zDALYs were calculated, based on the following included studies: for Kazakhstan 457 (95% CI 342–597), Viet Nam 5316 (95% CI 4382–6244), Asia 1,145,287 (90% CI 388,592–1,902,310), Africa 837,158 (90% CI 283,087–1,388,963), and worldwide rabies 5,920,014 (95% CI 1,547,860–10,290,815). This was followed by echinococcosis, the zDALYs in Peru were 2238 (95% CI 1931–2546), in China 1490 (95% CI 1442–1537), and worldwide cystic echinococcosis 5,935,463 (95% CI 4,497,316–7,377,636). Then, the zDALYs on cysticercosis for Mozambique were 2075 (95% CI 1476–2809), Cameroon 59,540 (95% CR 16,896–101,803), and Tanzania 34,455 (95% CI 12,993–76,193). Brucellosis in Kazakhstan were 2443 zDALYs (95% CI 2391–2496), and brucellosis and anthrax in Turkey 3538 zDALYs (95% CI 2567–6706). Finally, zDALYs on leptospirosis in New Zealand were 196, and Q fever in Netherlands 2843 (95% CI 1071–4603). The animal burden was superior to the human burden in the following studies: worldwide cystic echinococcosis (83%), brucellosis in Kazakhstan (71%), leptospirosis in New Zealand (91%), and brucellosis, and anthrax in Turkey (52%). Countries priorities on zoonoses can change if animal populations are taken into consideration.

Background: When we talk about zoonoses, it is undeniable that we have a human and animal population that has been isolated in studies over time. Besides human and animal health, zoonoses also impact the economy and society. Therefore, the integration of the analysis in this area is essential to optimize resources in public health decisions. We have new challenges in public health that we need to overcome in a more comprehensive method such as One Health. For better measures in public health, the dual burden of zoonoses seems a logical way to determine the integral impact of such diseases in society and thus take better measures to prevent and reduce the impact of these diseases. Methods: We follow the guidelines for “Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA). We search human and animal zoonoses on Embase, Ovid Medline, Scopus, Web of Science, and Google Scholar, from an unrestricted period until November 2021. For the search, we consider the Disability Adjusted Life Years (DALYs) for the human zoonotic burden and the animal zoonotic burden in monetary terms. A librarian collaborates to optimize the search string for the databases, and two reviewers screen eligible articles (first by title, then by abstracts, and finally, by full-text assessment.) For the analysis, we aim to convert the burden of zoonoses of all selected studies into the zoonotic Disability Adjusted Life Years (zDALYs) – including the human and animal components. Discussion: The study results will provide information on published studies that have accounted for the dual burden of zoonoses (both human and animal health aspects.) In addition, the synthesis of the available literature will address the knowledge gap in this area in order to know to what extent it is possible to convert the burden of human zoonoses to the animal burden of zoonoses and integrate them into a more comprehensive approach (dual burden of zoonoses.)

Zoonoses are diseases transmitted from (vertebrate) animals to humans. Control and prevention of these diseases require an appropriate way to measure health for prudent and well-balanced decisions in public health. We propose a framework that aims to explore, understand and open up a conversation about the non-monetary value of animals through environmental and normative ethics. As an example of its application, participants can choose what they are willing to give in exchange for curing an animal in hypothetical scenarios selecting a human health condition to suffer, the amount of money, and lifetime as a tradeoff. We believe that considering animals beyond their monetary value in public health decisions will contribute to a more rigorous assessment of the burden of zoonotic diseases, among other health decisions. This method might help us complement the existing metrics in health, adding more comprehensive values for animal and human health for the “One Health” approach.

Zoonoses are diseases transmitted from (vertebrate) animals to humans in the environment. The control and prevention of these diseases require an appropriate way to measure health value for prudent and well-balanced decisions in public health, production costs, and market values. Currently, the impact of diseases and animal disease control measures are typically assessed in monetary values, thus lacking consideration of other values such as emotional, societal, ecological, among others. Therefore, a framework is proposed that aims to explore, understand, and open up a conversation about the non-monetary value of animals through environmental and normative ethics. This method might help us complement the existing metrics in health, which are currently DALY and zDALY, adding more comprehensive values for animal and human health to the “One Health” approach. As an example of this framework application, participants can choose what they are willing to give in exchange for curing an animal in hypothetical scenarios selecting a human health condition to suffer, the amount of money, and lifetime as a tradeoff. Considering animals beyond their monetary value in public health decisions might contribute to a more rigorous assessment of the burden of zoonotic diseases, among other health decisions. This study is structured as follows: after a brief introduction of zoonoses, animal health, and health metrics, briefly, different environmental health perspectives are presented. Based on this, a framework for animal health decisions is proposed. This framework introduces the “anthropozoocentric interface” based on anthropocentrism and zoocentrism perspectives.

We express our appreciation of the response to our micronucleus paper 1 and are glad that our research findings are relevant to other findings on e-waste issues from the plethora of literature that we have read. We understand that there are confounding factors to consider when it comes to micronucleus assays. Based on our reading of other related studies, the use of buccal micronucleus assay for biomonitoring of e-waste workers is definitely possible because the micronucleus (MN) assay in exfoliated buccal cells is a useful and minimally invasive method for monitoring genetic damage (as also experienced among e-waste workers) in humans. The MN assay in buccal cells has been used since the 1980's to demonstrate the cytogenetic effects of environmental and occupational exposures, lifestyle factors, dietary deficiencies, and different diseases, but important knowledge gaps remain about the characteristics of micronuclei and other nuclear abnormalities, with the basic biology explaining the appearance of various cell types in buccal mucosa samples and effects of diverse staining procedures and scoring criteria in laboratories around the world. With these uncertainties, the human micronucleus project (HUMN) 2 has initiated a new international validation project for the buccal cell MN assay. They advised that future research should explore sources of variability in the assay (e.g., between laboratories and scorers, as well as inter-and intra-individual differences in subjects), and resolve key technical issues, such as the method of buccal cell staining, optimal criteria for classification of normal and degenerated cells and for scoring micronuclei and other abnormalities. The harmonization and standardization of the buccal MN assay will allow more reliable comparison of data among human populations and laboratories, evaluation of the assay's performance, and consolidation of its worldwide use for biomonitoring of DNA damage. 3 In this regard, the buccal cell MN assay was first proposed in 1983 and continues to gain popularity as a biomarker of genetic damage in numerous applications. More than 40 laboratories from many countries either have used or are currently using this assay, and the number of articles published annually is steadily increasing. Different issues related to the buccal cell MN assay were reviewed in several publications over the last decade. 4 Since the publication of the previous e-waste monitor in 2017, the number of studies on the adverse health effects from e-waste have increased. These studies have continued to highlight the dangers to human health from exposure to well-studied toxins, such as lead. Recently, research has found that unregulated e-waste recycling is associated with increasing numbers of adverse health effects. These include adverse birth outcomes, altered neurodevelopment, adverse learning outcomes, 5 DNA damage, 6 adverse cardiovascular effects, 7 adverse respiratory effects, 8 and adverse effects on the immune system. Additionally, the Micronucleus Assay Expert Group reported s...

No abstract